CardioDex
Disposable Solution for Closing Arterial Access Sites
Company Overview
Snapshot
Founded in January 2001, CardioDex operated with 1–10 employees. The company ceased operations in February 2013, marking a significant event in its trajectory.
Business overview
CardioDex developed, manufactured, and marketed disposable solutions for closing arterial access sites following endovascular catheterization procedures. Its core technology focused on expediting arterial closure through hemostasis without using foreign materials like glue, collagen, or sutures, relying instead on familiar balloon inflation/deflation techniques. The company's products were utilized in both diagnostic and therapeutic markets within the Health Tech & Life Sciences sector, specifically targeting medical devices, diagnostics devices, and medical treatment & therapeutics.
Log in to access full profile ›Company Intelligence Q&A
- What was CardioDex's primary focus?
- CardioDex focused on developing, manufacturing, and marketing disposable solutions for closing arterial access sites after endovascular catheterization procedures.
- When was CardioDex founded?
- CardioDex was founded in January 2001.
- What was the operational status of CardioDex?
- CardioDex ceased to operate in February 2013.
- What technology did CardioDex utilize for arterial closure?
- CardioDex's technology expedited arterial closure through hemostasis using balloon inflation/deflation techniques, avoiding foreign materials like glue, collagen, or sutures.
- Which markets did CardioDex serve?
- CardioDex's products were used in diagnostic and therapeutic markets.